Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare it read-only, idempotent, and non-destructive; the description adds substantial behavior: cascades through multiple endpoints, graceful degradation of LEI/FIGI enrichment, explicit 'unresolved' reporting, and returning figi_candidates on ambiguous matches. This far exceeds the annotation baseline.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but front-loaded with examples and the 'Use FIRST' directive, and it is structured into supported types with clear details. The bond parenthetical is dense but purposeful; slightly over-long, yet every sentence earns its place.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite no output schema, the description covers supported types, edge cases (non-equity instruments, ambiguous names, unresolved identifiers), and failure behavior (graceful degradation), so an agent has what it needs to call and interpret results correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so baseline is 3, but the description adds meaningful guidance beyond the schema: concrete values (AAPL, 0000320193), the ENTITY NAME ONLY restriction for bonds, and the ISIN-to-LEI behavior. This materially helps the agent invoke the tool correctly.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a precise purpose: resolving user-spoken names to canonical/official identifiers, with concrete examples (ticker, CIK, LEI, RxCUI) and explicitly positions itself as the 'FIRST' step when a name but no ID is known. It distinguishes from siblings like entity_profile and get_drug by focusing on name-to-ID resolution.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description says 'Use FIRST whenever you have a name but need an ID' and gives example phrasings. It also details supported types and input formats, but it doesn't explicitly contrast this with sibling tools (e.g., when to use entity_profile instead), leaving some exclusion reasoning implicit.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.4/5.0
Disambiguation2/5

Multiple tools have overlapping purposes (e.g., ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded; deep_research; bet_research and multiple polymarket tools). This makes it difficult for an agent to distinguish which tool to use.

Naming Consistency4/5

Tool names consistently use snake_case and follow a verb_noun or noun_verb pattern. However, some names are very long and descriptive (e.g., polymarket_kalshi_spread, scan_competitor_ai_presence), which is acceptable but slightly inconsistent in length.

Tool Count3/5

With 38 tools, the server is on the high side of reasonable. Many are meta-tools or query routers, which inflates the count. The scope is very broad, covering diverse domains, making the number somewhat justifiable but still feeling heavy.

Completeness3/5

For the Dailymed domain, tools cover label search, retrieval, history, and comparison. However, many other domains (e.g., finance, prediction markets) rely on a handful of routing tools (ask_pipeworx) rather than dedicated tools, leaving the coverage uneven and not fully self-contained.